For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 31-November 6, 2026
Drug pricing and PBMs Medicare’s second round of negotiated prices starts in two months. On January 1, negotiated prices for…
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Search Posts
The Economic Standard
Drug Reference Pricing Threatens Patient Health, Innovation
The Economic Standard cites Research Fellow Patrick Hedger and CEI’s event on drug reference pricing: Some recent proposals to lower drug prices are…
News Release
Foreign Reference Pricing Schemes Threaten Patient Health and America’s Leadership in Medical Innovation
International policy experts and patients gathered today in Washington, D.C. to discuss the potential impact of foreign reference pricing schemes, which have been proposed by the…
Blog
Proposals for and Problems with International Drug Reference Pricing
Healthcare costs remain top of mind in American politics. Polls consistently show that healthcare is one of, if not the top, priority for voters heading into the…
News Release
CEI Report Disputes Claims Tobacco 21 Laws Reduce Teen Smoking
A new Competitive Enterprise Institute report questions whether laws that hike the purchase age for tobacco and e-cigarette products to 21 actually reduce smoking rates…
News Release
International Experts Voice Concerns About International Pricing Index and Foreign Reference Pricing Proposals for Prescription Drugs
To address the cost of prescription medicines, the Trump administration and congressional leaders have proposed instituting international reference pricing policies, like the International Pricing Index…
The Wall Street Journal
Why the U.K. Isn’t Having Problems with Vaping
The Wall Street Journal cites Senior Fellow Michelle Minton on e-cigarettes: Michelle Minton of the Competitive Enterprise Institute says: “A ban on flavors,…